PRESTON REUGEBRINK: Open Payments
NPI 1770157851 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 9 payments from 6 companies in 2025. Trend: 2023 $24 · 2024 $51 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $96 |
| Bioventus LLC | 2 | $54 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| ARGENX US, INC. | 1 | $29 |
| MOXIMED, INC | 1 | $26 |
| SK Life Science, Inc. | 1 | $23 |
Products named: JOURNAVX, DUROLANE, INGREZZA, VYVGART HYTRULO, MISHA KNEE SYSTEM, SMALL, LEFT, EXOGEN ULTRASOUND BONE HEALING SYSTEM.
Industry payments across NV — which companies pay providers there.
